New studies found that Americans with type 2 diabetes who are taking GLP-1 drugs like Ozempic and Mounjaro could face an increased risk of rare eye conditions.

Researchers uncover ‘dangerous’ threat of global scam operation affecting millions as health regulators warn fraudulent ...

Two new studies that have been published recently show that people who have been taking weight loss drugs may have encountered an increased risk of serious eye conditions and vision loss.

Three new studies suggest that Ozempic and related diabetes and weight loss drugs may help protect the brain from strokes.

One study found a modest risk of developing non-arteritic anterior ischaemic optic neuropathy (NAOIN), a rare eye condition ...

The morbidly obese members of the so-called National Association to Advance Fat Acceptance (NAAFA) have predictably come out ...

Doctors and many patients say GLP-1 drugs can help solve the growing problem of obesity. But some bristle at the thought that obesity is a problem at all.

Stopping prescription weight loss drugs often leads to significant weight regain, according to a large-scale analysis of 11 ...

While Ozempic or Wegovy or any of the other brands may help users lose volume in their bodies, it's also causing a loss of ...

GLP-1 drugs often cause weight loss because they mimic the GLP-1 hormone the body naturally produces after eating. Appetite decreases as users feel fuller for longer. The meds are prescribed to people ...

Could popular diabetes and weight loss drugs like Ozempic actually protect your brain from stroke damage, or prevent strokes ...